vTv Therapeutics, Inc. (VTVT)
NGM · Common · CUSIP 918385105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VTVT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
918385105
Market Cap
Small Cap
IPO
7/30/2015 · $15.00/share
Business: vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.

Company Contact

CEO
Paul J. Sekhri
CFO
Michael Tung
Headquarters
3980 Premier Dr, Suite 310, High Point, NC 27265
Phone
336-841-0300
Fax
336-841-0310
Investor Relations
Lee Roth, Burns McClellan · lroth@burnsmc.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »